Nexus of infection with human immunodeficiency virus, pulmonary tuberculosis and visceral leishmaniasis: A case report from Bihar, India

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 1, 2005, Pages 30-32

  Pandey, Krishna ^a   Sinha, Prabhat K ^a   Ravidas, Vidya N ^a   Kumar, Nawin ^a   Verma, Neena ^a   Lal, Chandra S ^a   Bimal, Sanjeev ^a   Sur, Dipika ^b   Bhattacharya, Sujit K ^a  

^a RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASPIRATION; BITE; BRAIN SCINTISCANNING; CASE REPORT; CONVULSION; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; GLIOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MALE; SPLEEN; TREATMENT OUTCOME; TUBERCULOMA; UNCONSCIOUSNESS; URINE INCONTINENCE; VISCERAL LEISHMANIASIS; WESTERN BLOTTING; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; GENERAL APPARATUS, EQUIPMENT AND SUPPLIES; IMMUNOLOGY; LEISHMANIASIS;

HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; INDIA; LEISHMANIASIS; MALE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TUBERCULOSIS, PULMONARY;

EID: 17644401372     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.30     Document Type: Article

References (10)

1. World Bank, 2003. HIV/AIDS in South Asia, A Threat to Development, 2003. South Asia HIV/AIDS Update, World Bank Report. Washington, DC: World Bank.
2. AIDS in South and Southwest Asia, A Development Challenge, 2002. UNDP Special Programme on HIV/AIDS-HIV and Development Project Publication. Available from www.undp. org.in/hivaids/projectbrochure.htm.
3. Desjeux P, 1996. Leishmaniasis: public health aspects and control. Clin Dermatol 14: 417-423.
4. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S, 2000. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence in India. Trans R Soc Trop Med Hyg. 94: 696-697.
5. Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, Das P, Bhattacharya SK, 2003. Visceral leishmaniasis and HIV coinfection in Bihar, India (letter). J Acquir Immune Defic Syndr 32: 115-116.
6. Thakur CP, Narayan S, Ranjan A, 2003. Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? (letter). J Acquir Immune Defic Syndr 32: 572-573.
7. Russo R, Nigro L, Panarello G, Montineri A, 2003. Clinical survey of leishmaniasis/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART). Ann Trop Med Parasitol 97: 149-155.
8. Laguna F, 2003. Treatment of leishmaniasis in HIV-positive patients. Ann Trop Med Parasitol 97: 135-142.
9. Sinha PK, Ranjan A, Siddique NA, Anil CK, Priya A, Das P, Bhattacharya SK, 2003. Usefulness of voluntary counseling and testing center for HIV/AIDS: Bihar as an example. J Acquir Immune Defic Syndr 33: 407-408.
10. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD, 2004. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 38: 217-221.